Clinical Trials Directory

Trials / Completed

CompletedNCT03967145

Turkish Version of the Glaucoma Quality of Life-15 Questionnaire

Reliability and Validity of the Turkish Version of the Glaucoma Quality of Life-15 Questionnaire

Status
Completed
Phase
Study type
Observational
Enrollment
127 (actual)
Sponsor
Acibadem University · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers

Summary

Glaucoma is a disease with irreversible loss of visual field and optic neuropathy and is the most important cause of irreversible vision loss after cataract in the world. Although clinical evaluations reveal the level of glaucoma quantitatively, it is necessary to evaluate the impact of this pathology on daily functions and quality of life with a holistic perspective and to provide appropriate advice to patients according to the information obtained. Glaucoma Quality of Life -15 Questionnaire (GQoL-15) was developed by Nelson et al. in 2003 to evaluate the quality of life of glaucoma patients. The aim of this study is to translate GQoL-15 into Turkish and evaluate its test-retest reliability for Turkish-speaking population.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDetermining quality of lifeQuality of Life

Timeline

Start date
2019-05-27
Primary completion
2020-03-01
Completion
2020-03-01
First posted
2019-05-30
Last updated
2020-04-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03967145. Inclusion in this directory is not an endorsement.